Literature DB >> 11731130

Metabolic flux response to phosphoglucose isomerase knock-out in Escherichia coli and impact of overexpression of the soluble transhydrogenase UdhA.

F Canonaco1, T A Hess, S Heri, T Wang, T Szyperski, U Sauer.   

Abstract

Blocking glycolytic breakdown of glucose by inactivation of phosphoglucose isomerase (Pgi) in Escherichia coli led to a greatly reduced maximum specific growth rate. Examination of the operational catabolic pathways and their flux ratios using [U-(13)C(6)]glucose-labeling experiments and metabolic flux ratio analysis provide evidence for the pentose phosphate (PP) pathway as the primary route of glucose catabolism in the knock-out mutant. The resulting extensive flux through the PP pathway disturbs apparently the reducing power balance, since overexpression of the recently identified soluble transhydrogenase UdhA improves significantly the growth rate of the Pgi mutant. The presented results provide first evidence that UdhA restores the cellular redox balance by catalyzing electron transfer from NADPH to NADH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731130     DOI: 10.1111/j.1574-6968.2001.tb10892.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  49 in total

Review 1.  Metabolic flux analysis of Escherichia coli knockouts: lessons from the Keio collection and future outlook.

Authors:  Christopher P Long; Maciek R Antoniewicz
Journal:  Curr Opin Biotechnol       Date:  2014-03-28       Impact factor: 9.740

2.  Development of a Novel Plasmid-Free Thymidine Producer by Reprogramming Nucleotide Metabolic Pathways.

Authors:  Jin-Sook Kim; Min-Kyung Jeong; Bong-Seong Koo; Hyeon-Cheol Lee
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

3.  RpoS-mediated growth-dependent expression of the Escherichia coli tkt genes encoding transketolases isoenzymes.

Authors:  Il Lae Jung; Ki Heon Phyo; In Gyu Kim
Journal:  Curr Microbiol       Date:  2005-06-13       Impact factor: 2.188

4.  Synthesis of flavonoid O-pentosides by Escherichia coli through engineering of nucleotide sugar pathways and glycosyltransferase.

Authors:  So Hyun Han; Bong Gyu Kim; Jeong A Yoon; Youhoon Chong; Joong-Hoon Ahn
Journal:  Appl Environ Microbiol       Date:  2014-02-21       Impact factor: 4.792

5.  Multiple Optimal Phenotypes Overcome Redox and Glycolytic Intermediate Metabolite Imbalances in Escherichia coli pgi Knockout Evolutions.

Authors:  Douglas McCloskey; Sibei Xu; Troy E Sandberg; Elizabeth Brunk; Ying Hefner; Richard Szubin; Adam M Feist; Bernhard O Palsson
Journal:  Appl Environ Microbiol       Date:  2018-09-17       Impact factor: 4.792

6.  The Entner-Doudoroff Pathway Is an Essential Metabolic Route for Methylotuvimicrobium buryatense 5GB1C.

Authors:  Lian He; Joseph D Groom; Mary E Lidstrom
Journal:  Appl Environ Microbiol       Date:  2021-01-15       Impact factor: 4.792

7.  Genetic basis of growth adaptation of Escherichia coli after deletion of pgi, a major metabolic gene.

Authors:  Pep Charusanti; Tom M Conrad; Eric M Knight; Karthik Venkataraman; Nicole L Fong; Bin Xie; Yuan Gao; Bernhard Ø Palsson
Journal:  PLoS Genet       Date:  2010-11-04       Impact factor: 5.917

8.  Engineering cofactor flexibility enhanced 2,3-butanediol production in Escherichia coli.

Authors:  Keming Liang; Claire R Shen
Journal:  J Ind Microbiol Biotechnol       Date:  2017-11-07       Impact factor: 3.346

9.  Systematic phenome analysis of Escherichia coli multiple-knockout mutants reveals hidden reactions in central carbon metabolism.

Authors:  Kenji Nakahigashi; Yoshihiro Toya; Nobuyoshi Ishii; Tomoyoshi Soga; Miki Hasegawa; Hisami Watanabe; Yuki Takai; Masayuki Honma; Hirotada Mori; Masaru Tomita
Journal:  Mol Syst Biol       Date:  2009-09-15       Impact factor: 11.429

10.  Transcriptional effects of CRP* expression in Escherichia coli.

Authors:  Reza Khankal; Jonathan W Chin; Debashis Ghosh; Patrick C Cirino
Journal:  J Biol Eng       Date:  2009-08-24       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.